Diversified Agency Services acquires medical communications agency Excerpta Medica

NewsGuard 100/100 Score

Omnicom Group's (NYSE: OMC) Diversified Agency Services (DAS) has acquired Amsterdam-based medical communications agency Excerpta Medica www.excerptamedica.com from world-leading publisher Elsevier, a division of Reed Elsevier Group plc.

Excerpta Medica will become a division of DAS's Adelphi, a group of businesses that provide multiperspective healthcare solutions to the pharmaceutical industry. Excerpta will continue to operate as an independent business, with offices in Amsterdam, New Jersey and London.

The acquisition of Excerpta Medica will allow Adelphi to collaborate on an increasing number of wide-ranging global client assignments. Excerpta Medica's portfolio of strategic communications services includes publication planning, medical meetings and education, interactive solutions and customized publishing solutions.

"For years I've admired the work and reputation of Excerpta Medica. This has always been a best-in-class company," said Thomas L. Harrison, Chairman and CEO, Diversified Agency Services Division, Omnicom Group Inc. "With the acquisition of Excerpta we can align two related and strategic businesses to offer more value and innovation to our healthcare clients."  

Adelphi provides services in strategic marketing, marketing and business intelligence, real-world observational research and disease-specific programs, health and economic outcomes research, market access, pricing and research, health communications, medical education and strategic product development consultancy.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer